BIOMAT Database Logo BIOMAT Database Logo

Multicenter double-blind trial of interferon-gamma versus placebo in the treatment of rheumatoid arthritis. 1991

E M Lemmel, and W Gaus, and P H Hofschneider
Staatliches Rheumakrankenhaus Baden-Baden, FRG.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

E M Lemmel, and W Gaus, and P H Hofschneider
Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis.
August 1989, Arthritis and rheumatism,
E M Lemmel, and W Gaus, and P H Hofschneider
Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989.
February 2008, Arthritis and rheumatism,
E M Lemmel, and W Gaus, and P H Hofschneider
Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study.
September 1992, Annals of the rheumatic diseases,
E M Lemmel, and W Gaus, and P H Hofschneider
Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo.
April 1988, The Journal of rheumatology,
E M Lemmel, and W Gaus, and P H Hofschneider
Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis.
January 2001, Scandinavian journal of rheumatology,
E M Lemmel, and W Gaus, and P H Hofschneider
A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis.
January 1997, Arthritis and rheumatism,
E M Lemmel, and W Gaus, and P H Hofschneider
Tolmetin versus placebo for the treatment of rheumatoid arthritis: a sequential double-blind clinical trial.
May 1974, Current therapeutic research, clinical and experimental,
E M Lemmel, and W Gaus, and P H Hofschneider
Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. German Lymphokine Study Group.
January 1992, Rheumatology international,
E M Lemmel, and W Gaus, and P H Hofschneider
Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis.
June 1981, Annals of the rheumatic diseases,
E M Lemmel, and W Gaus, and P H Hofschneider
Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis.
January 1986, Clinical therapeutics,
Copied contents to your clipboard!